<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045673"><TermName>double-blinded</TermName><TermPronunciation>(DUH-bul BLINE-ded)</TermPronunciation><TermDefinition><DefinitionText>A clinical trial in which the medical staff, the patient, and the people who analyze the results do not know the specific type of treatment the patient receives until after the clinical trial is over.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705763" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;double-blinded&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705764" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;doble ciego&quot;" language="es" id="_4"/><SpanishTermName>doble ciego</SpanishTermName><SpanishTermDefinition><DefinitionText>Ensayo clínico en el cual ni el personal médico,  ni los pacientes ni las personas que analizan los resultados saben el tipo específico de tratamiento que recibe el paciente hasta después de que se termina el ensayo clínico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2009-04-10</DateLastModified></GlossaryTerm>
